Pramipeksol (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pramipeksol" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

8nih.gov

4^th place

8^th place

5doi.org

2^nd place

5^th place

4europa.eu

68^th place

28^th place

2drugs.com

399^th place

169^th place

2web.archive.org

1^st place

2^nd place

1termania.net

low place

34^th place

1drmed.org

low place

1,983^rd place

1sciencedirect.com

149^th place

140^th place

1archive.org

6^th place

9^th place

1semanticscholar.org

11^th place

51^st place

archive.org

Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (april 2009). »Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease«. Mayo Clin. Proc. 84 (4): 310–6. doi:10.4065/84.4.310. PMC 2665974. PMID 19339647.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

doi.org

Tan EK, Ondo W (2000). »Clinical characteristics of pramipexole-induced peripheral edema«. Arch Neurol. 57 (5): 729–732. doi:10.1001/archneur.57.5.729. PMID 10815140.
Napier, T. Celeste; Kirby, Alana; Persons, Amanda L. (2020). »The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson's disease«. Progress in Neuropsychopharmacology and Biological Psychiatry (v angleščini). 102: 109942. doi:10.1016/j.pnpbp.2020.109942. ... features of ICSDs [impulsive-compulsive spectrum disorders] during D2/D3R treatment are consistent with the pharmacological profile of the drugs, the known role of D2/D3R in these behaviors, and the neuroanatomical substrates of D2/D3R-expressing brain systems of ICSDs as shown by modern human imaging studies. While we pose that D2/D3R agonist treatment is sufficient to mediate ICSDs, there likely are many factors that overlay this profile, e.g., genetic vulnerabilities, brain disease state, and maladaptations to the chronic therapy.
Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (april 2009). »Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease«. Mayo Clin. Proc. 84 (4): 310–6. doi:10.4065/84.4.310. PMC 2665974. PMID 19339647.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Moore TJ; Glenmullen J; Mattison DR (december 2014). »Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs«. JAMA Internal Med. 174 (12): 1930–1933. doi:10.1001/jamainternmed.2014.5262. PMID 25329919.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Wolters ECh; van der Werf YD; van den Heuvel OA (2008). »Parkinson's disease-related disorders in the impulsive-compulsive spectrum«. J. Neurol. 255 Suppl 5: 48–56. doi:10.1007/s00415-008-5010-5. PMID 18787882. S2CID 24531331.

drmed.org

Planinec, Katarina. »Sindrom nemirnih nog - navodila za bolnike« (PDF). Združenje zdravnikov družinske medicine, Zavod za razvoj družinske medicine. Arhivirano iz prvotnega spletišča (PDF) dne 16. aprila 2021. Pridobljeno 29. marca 2021.

drugs.com

»Pramipexole Pregnancy and Breastfeeding Warnings«. Drugs.com. Pridobljeno 3. marca 2019.
»Pramipexole Dihydrochloride Monograph for Professionals«. Drugs.com. American Society of Health-System Pharmacists. Pridobljeno 22. marca 2019.

europa.eu

ema.europa.eu

»Sifrol EPAR«. European Medicines Agency. Pridobljeno 17. oktobra 2020.
»Mirapexin EPAR«. European Medicines Agency. Pridobljeno 17. oktobra 2020.
https://www.ema.europa.eu/en/documents/product-information/mirapexin-epar-product-information_sl.pdf Povzetek glavnih značilnosti zdravila Mirapexin, vpogled:16. 4. 2021.
https://www.ema.europa.eu/en/documents/overview/mirapexin-epar-summary-public_sl.pdf Povzetek EPAR za javnost, Mirapexin, vpogled: 16. 4. 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Tan EK, Ondo W (2000). »Clinical characteristics of pramipexole-induced peripheral edema«. Arch Neurol. 57 (5): 729–732. doi:10.1001/archneur.57.5.729. PMID 10815140.
Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (april 2009). »Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease«. Mayo Clin. Proc. 84 (4): 310–6. doi:10.4065/84.4.310. PMC 2665974. PMID 19339647.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Moore TJ; Glenmullen J; Mattison DR (december 2014). »Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs«. JAMA Internal Med. 174 (12): 1930–1933. doi:10.1001/jamainternmed.2014.5262. PMID 25329919.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Wolters ECh; van der Werf YD; van den Heuvel OA (2008). »Parkinson's disease-related disorders in the impulsive-compulsive spectrum«. J. Neurol. 255 Suppl 5: 48–56. doi:10.1007/s00415-008-5010-5. PMID 18787882. S2CID 24531331.

dailymed.nlm.nih.gov

»Mirapex- pramipexole dihydrochloride tablet«. DailyMed. 1. marec 2020. Pridobljeno 17. oktobra 2020.
»Mirapex ER- pramipexole dihydrochloride tablet, extended release«. DailyMed. 5. februar 2020. Pridobljeno 17. oktobra 2020.

nlm.nih.gov

»MedlinePlus Drug Information: Pramipexole (Systemic)«. United States National Library of Medicine. Arhivirano iz prvotnega spletišča dne 26. septembra 2006. Pridobljeno 27. septembra 2006.

ncbi.nlm.nih.gov

Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (april 2009). »Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease«. Mayo Clin. Proc. 84 (4): 310–6. doi:10.4065/84.4.310. PMC 2665974. PMID 19339647.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

sciencedirect.com

Napier, T. Celeste; Kirby, Alana; Persons, Amanda L. (2020). »The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson's disease«. Progress in Neuropsychopharmacology and Biological Psychiatry (v angleščini). 102: 109942. doi:10.1016/j.pnpbp.2020.109942. ... features of ICSDs [impulsive-compulsive spectrum disorders] during D2/D3R treatment are consistent with the pharmacological profile of the drugs, the known role of D2/D3R in these behaviors, and the neuroanatomical substrates of D2/D3R-expressing brain systems of ICSDs as shown by modern human imaging studies. While we pose that D2/D3R agonist treatment is sufficient to mediate ICSDs, there likely are many factors that overlay this profile, e.g., genetic vulnerabilities, brain disease state, and maladaptations to the chronic therapy.

semanticscholar.org

api.semanticscholar.org

Wolters ECh; van der Werf YD; van den Heuvel OA (2008). »Parkinson's disease-related disorders in the impulsive-compulsive spectrum«. J. Neurol. 255 Suppl 5: 48–56. doi:10.1007/s00415-008-5010-5. PMID 18787882. S2CID 24531331.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5534268/pramipeksol?query=pramipeksol&SearchIn=All Slovenski medicinski e-slovar, vpogled: 16. 4. 2021.

web.archive.org

Planinec, Katarina. »Sindrom nemirnih nog - navodila za bolnike« (PDF). Združenje zdravnikov družinske medicine, Zavod za razvoj družinske medicine. Arhivirano iz prvotnega spletišča (PDF) dne 16. aprila 2021. Pridobljeno 29. marca 2021.
»MedlinePlus Drug Information: Pramipexole (Systemic)«. United States National Library of Medicine. Arhivirano iz prvotnega spletišča dne 26. septembra 2006. Pridobljeno 27. septembra 2006.